MIF and the genetic basis of macrophage responsiveness

Current Immunology Reviews

Volumn 2, Issue 3, 2006, Pages 217-223

  Bucala, Richard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine; Genetic medicine; Innate immunity

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CD40 ANTIGEN; CHEMOKINE RECEPTOR CCR5; FC RECEPTOR; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; MIGRATION INHIBITION FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN P53; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR JAB1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AFRICA; APOPTOSIS; ASTHMA; CELLULAR IMMUNITY; CHROMOSOME 22Q; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME ACTIVATION; ETHNOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; IMMUNOREGULATION; INCIDENCE; INFLAMMATORY DISEASE; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; MACROPHAGE ACTIVATION; MALARIA; MOLECULAR EVOLUTION; MONOCYTE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; POPULATION DISTRIBUTION; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SARCOIDOSIS; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; ULCERATIVE COLITIS; UPREGULATION;

EID: 33747296188     PISSN: 15733955     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339506778018569     Document Type: Review

References (68)

1. Janeway CA, Travers P, Walport M, Shlomchik M. Innate Immunity. In Immunobiology. New York: Garland; 2005:37-100.
2. Barton G, Medzhotiv R. Toll-like receptor signaling pathways. Science 2003; 300: 1524-1525.
3. Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17: 593-623.
4. Kaufmann SHE. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis 2002; 61: 54-58.
5. Feldmann M, Brennan FM, Paleolog E, et al. Anti-TNFα therapy of rheumatoid arthritis: what can we learn about chronic disease? Novartis Found Symp 2004; 256: 53-69.
6. Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 2003; 3: 791-800.
7. Bozza M, Satoskar AR, Lin G, et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 1999; 189: 341-346.
8. Mitchell RA, Liao H, Chesney J, et al. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl Acad Sci USA 2002; 99: 345-350.
9. Bernhagen J, Calandra T, Mitchell RA, et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756-759.
10. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-902.
11. Bacher M, Metz CN, Calandra T, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci USA 1996; 93: 7849-7854.
12. Donnelly SC, Haslett C, Reid PT, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320-323.
13. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994; 33: 14144-14155.
14. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000; 275: 444-50.
15. Onodera S, Nishihira J, Iwabuchi K, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat ostenblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002; 277: 7865-7874.
16. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor. Arthritis Rheum 2001; 44: 1273-1280.
17. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
18. Bacher M, Meinhardt A, Lan HY, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997; 150: 235-246.
19. Fingerle-Rowson G, Koch P, Bikoff R, et al. Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am J Pathol 2003; 162: 47-56.
20. Paralkar V, Wistow G. Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 1994; 19: 48-51.
21. Mitchell R, Bacher M, Bernhagen J, Pushkarskaya T, Seldin MF, Bucala R. Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J Immunol 1995; 154: 3863-70,
22. Suzuki M, Sugimoto H, Nakagawa A, Tenaka I, Nishihira J, Sakai M. Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Structural Biology 1996; 3: 259-66.
23. Sun HW, Bernhagen J, Bucala R, Lolis E. Crystal structure at 2.6- A resolution of human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 1996; 93: 5191-5196.
24. Leng L, Metz C, Fang Y, et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-1476.
25. Leng L, Bucala R. Insight into the biology of Macrophage Migration Inhibitory Factor (MIF) revealed by the cloning of its cell surface receptor. Cell Research 2006; 16: 162-168.
26. Mitchell RA, Metz CN, Peng T, Bucala R. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J Biol Chem 1999; 274: 18100-6.
27. Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 2000; 408: 211-216.
28. Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med 1999; 190: 1375-1382.
29. Fingerle-Rowson G, Satoskar A, Bucala R. Macrophage migration inhibitory factor (MIF)-deficient mice. In Cytokine Knockouts. Edited by Fantuzzi G. Totowa NJ. Humana Press; 2003:361-378.
30. Rosengren E, Bucala R, Aman P, et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Molecular Medicine 1996; 2: 143-149.
31. Bendrat K, Al-Abed Y, Callaway DJ, et al. Biochemical and mutational investigations of the enzymatic activity of macrophage migration inhibitory factor. Biochemistry 1997; 36: 15356-15362.
32. Stamps SL, Fitzgerald MC, Whitman CP. Characterization of the role of the amino-terminal proline in the enzymatic activity catalyzed by macrophage migration inhibitory factor. Biochemistry 1998; 37: 10195-202.
33. Lubetsky JB, Swope M, Dealwis C, Blake P, Lolis E. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 1999; 38: 7346-54.
34. Swope M, Sun HW, Blake PR, Lolis E. Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J 1998; 17: 3534-41.
35. Hermanowski-Vosatka A, Mundt SS, Ayala JM, et al. Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 1999; 38: 12841-12949.
36. Senter PD, Al-Abed Y, Metz CN, et al. Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc Natl Acad Sci USA 2002; 99: 144-9.
37. Bernhagen J, Bacher M, Calandra T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 1996; 183: 277-82.
38. Martiney JA, Sherry B, Metz CN, et al. Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes. Possible role in the pathogenesis of malarial anemia. Infect Immun 2000; 68: 2259-2267.
39. Shimizu T, Ohkawara A, Nishihira J, Sakamoto W. Identification of macrophage migration inhibitory factor (MIF) in human skin and its immmunohistochemical localization. FEBS Letters 1996; 381: 199-202.
40. Waeber G, Calandra T, Roduit R, et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Nat Acad Sci USA 1997; 94: 4782-7.
41. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Molecular Medicine 1995; 1: 781-8.
42. Tesch GH, Nikolic-Paterson DJ, Metz CN, et al. Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J Am Soc Nephrol 1998; 9: 417-24.
43. Fingerle-Rowson GR, Bucala R. Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 2001; 79: 368-375.
44. Baugh JA, Chitnis S, Donnelly SC, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002; 3: 170-176.
45. Plant BJ, Gallagher CG, Bucala R, et al. Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism. Am J Respir Crit Care Med 2005; 172: 1412-1415.
46. Mizue Y, Ghani S, Leng L, et al. Role for Macrophage Migration Inhibitory Factor (MIF) in Asthma. Proc Natl Acad Sci USA 2005; 102: 14410-14415.
47. Donn RP, Shelley E, Ollier WE, Thomson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 1782-1785.
48. De Benedetti F, Meazza C, Vivarelli M, et al. Functional and prognostic relevance of the -173 polymorphism of the MIT gene in systemic juvenile idiopathic arthritis. Arthritis Rheum 2003; 48: 1398-1407.
49. Donn R, Alourfi Z, Zeggini E, et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis and Rheumatism 2004; 50: 1604-1610.
50. Radstake TR, Sweep FC, Welsing P, et al. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 2005; 52: 3020-3029.
51. Gregersen P, Bucala R. MIF, Mif alleles, and the Genetics of Inflammatory Disorders. Incorporating Disease Outcome into the Definition of Phenotype. Arthritis Rheum 2003; 48: 1171-1176.
52. Donn RP, Ray DW. Macrophage migration inhibitory factor. molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol 2004; 182: 1-9.
53. Amoli M, Donn R, Thomson W, et al. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum. J Rheumatol 2002; 29: 1671-1673.
54. Donn RP, Plant D, Jury F, et al. Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis. J Investi Dermatol 2004; 123: 484-487.
55. Nohara H, Okayam N, Inoue N, et al. Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39: 242-246.
56. Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M. Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Res Crit Care Med 2004; 169: 1014-8.
57. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95: 11383-11388.
58. Calandra T, Echtenacher B, Le Roy D, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000; 6: 164-169.
59. Koebernick H, Grode L, David JR, et al. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimuriumi. Proc Nat Acad Sci USA 2002; 99: 13681-13686.
60. Rodriguez-Sosa M, Rosas LE, David JR, Bojalil R, Satoskar AR, Terrazas LI. Macrophage migration inhibitory factor plays a critical role in mediating protection against the helminth parasite Taenia crassiceps. Infect Immun 2003; 71: 1247-1254.
61. McDevitt MA, Xie J, Shanmugasundaram G, et al. A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia. J Exp Med 2006; 203: 1185-1196.
62. Satoskar A, Bozza M, Rodriguez Sosa M, Lin G, David JR. Migration inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infection Immun 2001; 69: 906-911.
63. Beishuizen A, Thijs LG, Haanen C, et al. Macrophage migration inhibitory factor and hypothalamic-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001; 86: 2811-2816.
64. Joshi PC, Poole GV, Sachdev VZX, Jones Q. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor. Res Commun Mol Path and Pharm 2000; 107: 13-20.
65. Janeway CA, Travers P, Walport M, Shlomchik M. Antigen Presentation to T Lymphocytes. In Immunobiology. New York. Garland; 2005:169-201.
66. Chaisanvaneeyakorn S, Moore J, Othoro C, et al. Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood. J Infect Dis 2002; 186: 1371-1375.
67. Cooke GS, Hill AV. Genetics of susceptibility to human infectious disease. Nat Rev Genet 2001; 2: 967-977.
68. Zhong X, Leng L, Beitin A, et al. Simultaneous detection of microsatellite repeats and SNPs in the macrophage migration inhibitory factor (MIF) gene by thin-film biosensor chips and application to rural field studies. Nucleic Acids Res 2005; 33: 121-129.